Viewing Study NCT05926960


Ignite Creation Date: 2025-12-25 @ 2:09 AM
Ignite Modification Date: 2025-12-26 @ 4:47 AM
Study NCT ID: NCT05926960
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-12-18
First Post: 2023-04-03
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study Comparing 3 Study Medicines (Encorafenib, Binimetinib, Pembrolizumab) to 2 Study Medicines (Ipilimumab and Nivolumab) in Patients With Advanced Melanoma
Sponsor: Pfizer
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module